Towards Healthcare
Respiratory Drugs Market Size and Growth by 5.8% CAGR

Respiratory Drugs Market Size Envisioned at USD 28.11 Billion by 2032

The report covers Respiratory Drugs Market Trends and Companies such as GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, Mylan Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd. This market is segmented by disease type; by drug class; by distribution channel; by route of administration. Geographically, the market spans North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Respiratory Drugs Market Assessment

  • Overview
  • Global Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • Global Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • Global Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • Global Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Respiratory Drugs Market Assessment

  • Overview
  • North America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • North America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • North America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • North America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Europe Respiratory Drugs Market Assessment

  • Overview
  • Europe Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • Europe Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • Europe Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • Europe Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Asia Pacific Respiratory Drugs Market Assessment

  • Overview
  • Asia Pacific Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • Asia Pacific Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • Asia Pacific Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • Asia Pacific Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Middle East and Africa Respiratory Drugs Market Assessment

  • Overview
  • Middle East and Africa Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • Middle East and Africa Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • Middle East and Africa Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • Middle East and Africa Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

South America Respiratory Drugs Market Assessment

  • Overview
  • South America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Respiratory Tract Infection
    • Allergic Rhinitis
    • Cystic Fibrosis (CF)
    • Others
  • South America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Bronchodilators
    • Corticosteroids
    • Combination Drugs
    • Antibiotics
    • Target Therapy
    • Immunotherapy
    • CFTR
    • Others
  • South America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Nasal
    • Injectable
  • South America Respiratory Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Companies Profile

  • GlaxoSmithKline Plc
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • AstraZeneca Plc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Mylan Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.

Conclusion & Recommendations

  • Insight Code: 5137
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Respiratory disorders affect the lungs, airways, and respiratory muscles, leading to coughing, wheezing, shortness of breath, and chest tightness.

Corticosteroids are crucial in managing respiratory disorders due to their anti-inflammatory properties, which help reduce inflammation in the airways and lungs. By alleviating inflammation, corticosteroids can improve lung function, relieve symptoms like coughing and wheezing, and prevent exacerbations in conditions like asthma and COPD, leading to better overall respiratory health.

One of the hurdles in the respiratory drugs market is the high cost of medications, devices, and healthcare services, which can limit access to care for individuals without adequate insurance coverage or financial resources.

Centers for Disease Control and Prevention, National Institute of Health, World Health Organization, National Cancer Institute, MedlinePlus.gov., Forum of International Respiratory Societies.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509